Enfusion Inc Stock Price, News & Analysis

Clearwater Analytics (NYSE: CWAN) has completed its acquisition of Enfusion, Inc. (NYSE: ENFN) in a deal valued at approximately $1.5 billion. The strategic combination creates the industry's first unified, cloud-native front-to-back platform for institutional investors.

The integration combines Enfusion's front-office capabilities with Clearwater's middle and back-office solutions, eliminating data silos and streamlining investment operations. The expanded platform offers seamless integration across workflows, a single security master, and real-time views of positions, performance, and risk.

The acquisition significantly expands Clearwater's international presence, with Enfusion generating 38% of its revenue from Europe and Asia. The combined company will serve clients from global hubs including Boise, New York, Edinburgh, and New Delhi. The first wave of integration milestones, including unified dashboards and streamlined reconciliation, is already underway.

Clearwater Analytics (NYSE: CWAN) and Enfusion (NYSE: ENFN) have announced preliminary election results for their merger consideration ahead of their expected April 21, 2025 closing. Based on the April 16, 2025 election deadline results:

- 45.5% of Enfusion shareholders elected for Mixed Consideration ($5.85 cash + Clearwater shares) - 40.9% chose Cash Consideration ($10.87 per share) - 6.1% selected Stock Consideration - 7.6% made no valid election

With a Final Parent Stock Price of $23.2440 and 129,995,464 Eligible Shares, the total Aggregate Consideration is valued at $1.41 billion. The Cash Consideration option is oversubscribed and will be subject to proration. The transaction is expected to qualify as a reorganization under Section 368(a) of the Internal Revenue Code.

Clearwater Analytics (NYSE: CWAN) and Enfusion (NYSE: ENFN) have announced the election deadline for Enfusion shareholders to choose their preferred form of merger consideration. The deadline is set for 5:00 p.m. Eastern Time on April 16, 2025.

The merger consideration options include: (1) $5.85 in cash plus shares of Clearwater Class A common stock determined by the Per Share Parent Stock Amount, (2) Clearwater Class A common stock based on the Exchange Ratio, or (3) cash equal to the Aggregate Consideration Per Share. The final value will be equalized across all options.

The transaction is expected to close around April 21, 2025, subject to Enfusion shareholder approval and other closing conditions. Election materials have been distributed to Enfusion shareholders of record as of March 20, 2025. Shareholders must submit their completed election materials to Computershare Trust Company by the deadline.

Enfusion (NYSE: ENFN) reported strong Q4 and full-year 2024 financial results, showcasing steady growth across key metrics. Q4 revenue reached $52.9 million, up 13.9% year-over-year, with a gross profit of $36.5 million and 69.0% margin. The company achieved a net income of $0.2 million and Adjusted EBITDA of $12.3 million, up 25.3% from the previous year.

Full-year 2024 performance showed total revenue of $201.6 million, representing a 15.5% increase from 2023's $174.5 million. The company maintained strong profitability with a 67.8% gross profit margin and 21.2% Adjusted EBITDA margin. Annual Recurring Revenue reached $210.4 million, up 13.6% year-over-year, while the Net Dollar Retention Rate improved to 103.0%.

Notably, Enfusion added 41 new clients in Q4, bringing the total client count to 916. The company has entered into a definitive agreement to be acquired by Clearwater Analytics, with the transaction expected to close in Q2 2025, subject to shareholder and regulatory approvals.

Clearwater Analytics Holdings (NYSE: CWAN) and Enfusion Inc. (NYSE: ENFN) announced a significant milestone in their proposed acquisition deal with the expiration of the Hart-Scott-Rodino Antitrust Improvements Act waiting period on February 24, 2025. This development marks the fulfillment of a key closing condition for the transaction.

The acquisition, which combines two leading SaaS-based investment management solution providers, is anticipated to close in the second quarter of 2025. The completion remains subject to customary closing conditions, including obtaining Enfusion shareholder approval.

Clearwater Analytics Holdings (NYSE: CWAN) has announced the launch of a proposed $800 million senior secured Term Loan B Facility, due 2033. The company plans to use the proceeds from this Term Loan, along with equity issuance, to finance its previously announced acquisition of Enfusion, Inc. (NYSE: ENFN). The total transaction price for the Enfusion acquisition is approximately $1.5 billion. Clearwater Analytics is a leading global provider of SaaS-based investment management, accounting, reporting, and analytics solutions.

Clearwater Analytics (NYSE: CWAN) has announced its acquisition of Enfusion (NYSE: ENFN) for approximately $1.5 billion, or $11.25 per share in a mixed cash-stock deal. The transaction includes a $30 million payment to terminate Enfusion's tax receivable agreement.

The strategic acquisition aims to create the first cloud-native front-to-back platform for the investment management industry, combining Enfusion's front-office capabilities with Clearwater's middle and back-office solutions. The merger is expected to expand Clearwater's TAM by $1.9 billion and accelerate global growth, particularly in Europe and Asia where Enfusion generates 38% of its revenue.

Enfusion's preliminary full-year 2024 revenue is expected at $201-202 million (15-16% YoY growth) with ARR of $210-211 million (13-14% YoY growth). The deal is anticipated to close in Q2 2025, subject to approvals. Clearwater expects to achieve $20 million in cost savings and improve Enfusion's Adjusted EBITDA margin by 400 bps in the first year and another 400 bps in the second year post-close.

Orbus Software, a leading SaaS enterprise transformation software provider, has secured a significant growth equity investment from FTV Capital, alongside existing investor SilverTree Equity. The investment will fuel Orbus's U.S. expansion, enhance platform technology and AI capabilities, and strengthen its position in regulated industries.

The company's enterprise architecture platform, OrbusInfinity, helps IT and business leaders manage digital transformation initiatives, reduce costs and risks, and ensure regulatory compliance. Orbus recently acquired Capsifi, a Sydney-based business architecture software provider, strengthening its APAC presence. The company serves notable customers including UPS, AutoZone, and Alaska Airlines, and has been recognized as a leader in the 2024 Gartner Magic Quadrant for Enterprise Architecture Tools.

Enfusion (NYSE: ENFN), a leading SaaS solutions provider for investment managers, has announced its executive participation in two upcoming investor events. Chief Financial Officer Brad Herring and Chief Operating Officer Neal Pawar will attend the Wells Fargo 8th Annual TMT Summit on December 3, 2024, and the UBS Global Technology and AI Conference on December 4, 2024. Live audio webcasts and archived replays will be accessible through Enfusion's Investor Relations website.